TLE1 and neoplasm: Analysis from the first sample showed the tumor cells were diffusely positive for Lu-5, P40, CD56, and vimentin, focally positive for transducin-like enhancer of split-1 (TLE1), and rarely positive for synaptophysin and DOG1.